- Home
- GNPX vs BQ Comparison
GNPX vs BQ Comparison
Compare GNPX & BQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNPX
- BQ
- Stock Information
- Founded
- GNPX 2009
- BQ 2008
- Country
- GNPX United States
- BQ China
- Employees
- GNPX N/A
- BQ N/A
- Industry
- GNPX Biotechnology: Pharmaceutical Preparations
- BQ Other Specialty Stores
- Sector
- GNPX Health Care
- BQ Consumer Discretionary
- Exchange
- GNPX Nasdaq
- BQ Nasdaq
- Market Cap
- GNPX 10.8M
- BQ 8.7M
- IPO Year
- GNPX 2018
- BQ 2020
- Fundamental
- Price
- GNPX $5.85
- BQ $3.00
- Analyst Decision
- GNPX
- BQ
- Analyst Count
- GNPX 0
- BQ 0
- Target Price
- GNPX N/A
- BQ N/A
- AVG Volume (30 Days)
- GNPX 1.8M
- BQ 1.5M
- Earning Date
- GNPX 11-14-2025
- BQ 07-21-2025
- Dividend Yield
- GNPX N/A
- BQ N/A
- EPS Growth
- GNPX N/A
- BQ N/A
- EPS
- GNPX N/A
- BQ N/A
- Revenue
- GNPX N/A
- BQ $64,617,102.00
- Revenue This Year
- GNPX N/A
- BQ N/A
- Revenue Next Year
- GNPX N/A
- BQ N/A
- P/E Ratio
- GNPX N/A
- BQ N/A
- Revenue Growth
- GNPX N/A
- BQ N/A
- 52 Week Low
- GNPX $4.60
- BQ $1.62
- 52 Week High
- GNPX $117.50
- BQ $56.10
- Technical
- Relative Strength Index (RSI)
- GNPX 57.62
- BQ 40.38
- Support Level
- GNPX $7.71
- BQ $2.77
- Resistance Level
- GNPX $9.89
- BQ $72.74
- Average True Range (ATR)
- GNPX 1.35
- BQ 7.46
- MACD
- GNPX -0.24
- BQ -0.89
- Stochastic Oscillator
- GNPX 43.95
- BQ 0.33
About GNPX Genprex Inc.
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.
About BQ Boqii Holding Limited representing
Boqii Holding Ltd operates in the business of selling pet products through online stores. The store provides pet foods, health products, pet grooming products, pet bathing products, pet toys, fish tank, aquatic fertilizer, temperature control equipment, oxygen pump and other related products. Also, the company sells its products through offline channels to pet stores and hospitals.